Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Cross

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
BMJ Sexual & Reproductive Health|November 15, 2019
High rates of treatment failure for <i>Mycoplasma genitalium</i> among men and women attending a sexual health clinicKatie Jane Ovens, John Joseph Reynolds-Wright, Elizabeth Louise Anne Cross, et al.
Bulletin of the World Health Organization|August 1, 2006
HIV testing in national population-based surveys: experience from the Demographic and Health SurveysVinod Mishra, Martin Vaessen, J Ties Boerma, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2009
Comparison of HIV prevalence estimates from sentinel surveillance and a national population-based survey in Uganda, 2004-2005Joshua Musinguzi, Wilford Kirungi, Alex Opio, et al.
The New England Journal of Medicine|March 10, 2006
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis BChing-Lung Lai, Daniel Shouval, Anna S Lok, et al.
The New England Journal of Medicine|November 29, 2013
Contagious diseases in the United States from 1888 to the presentWillem G van Panhuis, John Grefenstette, Su Yon Jung, et al.
Gastroenterology|June 10, 2006
Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis BMorris Sherman, Cihan Yurdaydin, Jose Sollano, et al.
The New England Journal of Medicine|March 10, 2006
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis BTing-Tsung Chang, Robert G Gish, Robert de Man, et al.
JAMA Neurology|March 27, 2013
Interferon beta use and disability prevention in relapsing-remitting multiple sclerosisBenjamin M Greenberg, Laura Balcer, Peter A Calabresi, et al.
Hepatology (Baltimore, Md.)|December 10, 2008
Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovirNancy Leung, Cheng-Yuan Peng, Hie-Won Hann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2021
Charting a global research strategy for progressive MS-An international progressive MS Alliance proposalAlan J Thompson, William Carroll, Olga Ciccarelli, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
BMJ Sexual & Reproductive Health|November 15, 2019
High rates of treatment failure for <i>Mycoplasma genitalium</i> among men and women attending a sexual health clinicKatie Jane Ovens, John Joseph Reynolds-Wright, Elizabeth Louise Anne Cross, et al.
Bulletin of the World Health Organization|August 1, 2006
HIV testing in national population-based surveys: experience from the Demographic and Health SurveysVinod Mishra, Martin Vaessen, J Ties Boerma, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2009
Comparison of HIV prevalence estimates from sentinel surveillance and a national population-based survey in Uganda, 2004-2005Joshua Musinguzi, Wilford Kirungi, Alex Opio, et al.
The New England Journal of Medicine|March 10, 2006
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis BChing-Lung Lai, Daniel Shouval, Anna S Lok, et al.
The New England Journal of Medicine|November 29, 2013
Contagious diseases in the United States from 1888 to the presentWillem G van Panhuis, John Grefenstette, Su Yon Jung, et al.
Gastroenterology|June 10, 2006
Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis BMorris Sherman, Cihan Yurdaydin, Jose Sollano, et al.
The New England Journal of Medicine|March 10, 2006
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis BTing-Tsung Chang, Robert G Gish, Robert de Man, et al.
JAMA Neurology|March 27, 2013
Interferon beta use and disability prevention in relapsing-remitting multiple sclerosisBenjamin M Greenberg, Laura Balcer, Peter A Calabresi, et al.
Hepatology (Baltimore, Md.)|December 10, 2008
Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovirNancy Leung, Cheng-Yuan Peng, Hie-Won Hann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2021
Charting a global research strategy for progressive MS-An international progressive MS Alliance proposalAlan J Thompson, William Carroll, Olga Ciccarelli, et al.
Pageof 2